Bacillus Calmette–Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer

BACKGROUND: Bacillus Calmette–Guérin (BCG) is currently the most effective intravesical therapy for non-muscle-invasive bladder cancer (NMIBC) as it can prevent disease recurrence and progression and lower mortality. However, the response rates to BCG vary widely and are dependent on a multitude of...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Fei, Liu, Ming, Zhang, Wei, Tang, Min, Zhang, Jinsong, Li, Hexin, Zou, Lihui, Zhang, Rui, Liu, Yudong, Li, Lin, Ma, Jie, Zhang, Yaqun, Chen, Meng, Xiao, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930202/
https://www.ncbi.nlm.nih.gov/pubmed/35311085
http://dx.doi.org/10.3389/fonc.2022.842182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930202/
https://www.ncbi.nlm.nih.gov/pubmed/35311085
http://dx.doi.org/10.3389/fonc.2022.842182

Ejemplares similares